Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Market Cap	269.71B
Revenue (ttm)	160.09B
Net Income (ttm)	-2.64B
Shares Out	68.45M
EPS (ttm)	-39.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,139
Average Volume	63,178
Open	3,935.00
Previous Close	3,915.00
Day's Range	3,875.00 - 3,940.00
52-Week Range	3,500.00 - 6,810.00
Beta	0.97
RSI	42.72
Earnings Date	May 13, 2025

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 554
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003000

Financial Performance

In 2024, Bukwang Pharmaceutical's revenue was 160.09 billion, an increase of 27.13% compared to the previous year's 125.93 billion. Losses were -2.64 billion, -91.57% less than in 2023.